BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23625935)

  • 21. The identification of a novel natural activator of p300 histone acetyltranferase provides new insights into the modulation mechanism of this enzyme.
    Dal Piaz F; Tosco A; Eletto D; Piccinelli AL; Moltedo O; Franceschelli S; Sbardella G; Remondelli P; Rastrelli L; Vesci L; Pisano C; De Tommasi N
    Chembiochem; 2010 Apr; 11(6):818-27. PubMed ID: 20373302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ZZ domain of p300 mediates specificity of the adjacent HAT domain for histone H3.
    Zhang Y; Xue Y; Shi J; Ahn J; Mi W; Ali M; Wang X; Klein BJ; Wen H; Li W; Shi X; Kutateladze TG
    Nat Struct Mol Biol; 2018 Sep; 25(9):841-849. PubMed ID: 30150647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of new RNF126-based p300/CBP degraders.
    Lei YH; Tang Q; Ni Y; Li CH; Luo P; Huang K; Chen X; Zhu YX; Wang NY
    Bioorg Chem; 2024 Jul; 148():107427. PubMed ID: 38728911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.
    Picaud S; Fedorov O; Thanasopoulou A; Leonards K; Jones K; Meier J; Olzscha H; Monteiro O; Martin S; Philpott M; Tumber A; Filippakopoulos P; Yapp C; Wells C; Che KH; Bannister A; Robson S; Kumar U; Parr N; Lee K; Lugo D; Jeffrey P; Taylor S; Vecellio ML; Bountra C; Brennan PE; O'Mahony A; Velichko S; Müller S; Hay D; Daniels DL; Urh M; La Thangue NB; Kouzarides T; Prinjha R; Schwaller J; Knapp S
    Cancer Res; 2015 Dec; 75(23):5106-5119. PubMed ID: 26552700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing the reaction coordinate of the p300/CBP histone acetyltransferase with bisubstrate analogs.
    Karukurichi KR; Cole PA
    Bioorg Chem; 2011 Feb; 39(1):42-7. PubMed ID: 21111442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis.
    Rai R; Sun T; Ramirez V; Lux E; Eren M; Vaughan DE; Ghosh AK
    J Cell Mol Med; 2019 Apr; 23(4):3026-3031. PubMed ID: 30710427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells.
    Trisciuoglio D; Ragazzoni Y; Pelosi A; Desideri M; Carradori S; Gabellini C; Maresca G; Nescatelli R; Secci D; Bolasco A; Bizzarri B; Cavaliere C; D'Agnano I; Filetici P; Ricci-Vitiani L; Rizzo MG; Del Bufalo D
    Clin Cancer Res; 2012 Jan; 18(2):475-86. PubMed ID: 22068659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.
    Chaikuad A; Lang S; Brennan PE; Temperini C; Fedorov O; Hollander J; Nachane R; Abell C; Müller S; Siegal G; Knapp S
    J Med Chem; 2016 Feb; 59(4):1648-53. PubMed ID: 26731131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of PCAF histone acetyltransferase, cytotoxicity and cell permeability of 2-acylamino-1-(3- or 4-carboxy-phenyl)benzamides.
    Park WJ; Ma E
    Molecules; 2012 Nov; 17(11):13116-31. PubMed ID: 23128090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP.
    Crump NT; Hazzalin CA; Bowers EM; Alani RM; Cole PA; Mahadevan LC
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7814-9. PubMed ID: 21518915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo.
    Hassig CA; Symons KT; Guo X; Nguyen PM; Annable T; Wash PL; Payne JE; Jenkins DA; Bonnefous C; Trotter C; Wang Y; Anzola JV; Milkova EL; Hoffman TZ; Dozier SJ; Wiley BM; Saven A; Malecha JW; Davis RL; Muhammad J; Shiau AK; Noble SA; Rao TS; Smith ND; Hager JH
    Mol Cancer Ther; 2008 May; 7(5):1054-65. PubMed ID: 18483295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-histone acetyltransferase activity from allspice extracts inhibits androgen receptor-dependent prostate cancer cell growth.
    Lee YH; Hong SW; Jun W; Cho HY; Kim HC; Jung MG; Wong J; Kim HI; Kim CH; Yoon HG
    Biosci Biotechnol Biochem; 2007 Nov; 71(11):2712-9. PubMed ID: 17986787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the SANT domain of tension-induced/inhibited proteins (TIPs), novel partners of the histone acetyltransferase p300, on p300 activity and TIP-6-induced adipogenesis.
    Badri KR; Zhou Y; Dhru U; Aramgam S; Schuger L
    Mol Cell Biol; 2008 Oct; 28(20):6358-72. PubMed ID: 18710950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of the p300 histone acetyltransferase bound to acetyl-coenzyme A and its analogues.
    Maksimoska J; Segura-Peña D; Cole PA; Marmorstein R
    Biochemistry; 2014 Jun; 53(21):3415-22. PubMed ID: 24819397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112.
    Zucconi BE; Luef B; Xu W; Henry RA; Nodelman IM; Bowman GD; Andrews AJ; Cole PA
    Biochemistry; 2016 Jul; 55(27):3727-34. PubMed ID: 27332697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300.
    Hyndman BD; Thompson P; Bayly R; Côté GP; LeBrun DP
    Biochim Biophys Acta; 2012 May; 1819(5):446-53. PubMed ID: 22387215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy.
    Arif M; Kumar GV; Narayana C; Kundu TK
    J Phys Chem B; 2007 Oct; 111(41):11877-9. PubMed ID: 17894486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone acetyltransferase p300 is induced by p38MAPK after photodynamic therapy: the therapeutic response is increased by the p300HAT inhibitor anacardic acid.
    Tsai YJ; Tsai T; Peng PC; Li PT; Chen CT
    Free Radic Biol Med; 2015 Sep; 86():118-32. PubMed ID: 26001729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live-cell studies of p300/CBP histone acetyltransferase activity and inhibition.
    Dancy BM; Crump NT; Peterson DJ; Mukherjee C; Bowers EM; Ahn YH; Yoshida M; Zhang J; Mahadevan LC; Meyers DJ; Boeke JD; Cole PA
    Chembiochem; 2012 Sep; 13(14):2113-21. PubMed ID: 22961914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.